TCM Biotech International Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	216.39	232.98	504.13	89.85	58.26	34.27
Short-Term Investments	300	300	-	0.09	-	-
Cash & Short-Term Investments	516.39	532.98	504.13	89.94	58.26	34.27
Cash Growth	-	5.72%	460.55%	54.38%	70.01%	17.11%
Accounts Receivable	157.75	139.96	259.08	225.83	190.68	167.95
Other Receivables	0.17	1.69	3.61	3.94	0.03	0.09
Receivables	157.93	141.65	262.69	229.77	190.71	168.05
Inventory	144.46	132.24	208.36	193.25	203.33	207.39
Prepaid Expenses	5.33	4.96	4.46	0.65	17.08	18.46
Other Current Assets	0.61	0.15	1.51	0.13	0.74	0.46
Total Current Assets	824.72	811.98	981.15	513.74	470.11	428.62
Property, Plant & Equipment	285.21	291.91	293.71	301.74	285.36	291.91
Long-Term Investments	28.76	30	-	-	-	-
Other Intangible Assets	2.35	5.06	8.01	10.24	13.21	15.2
Long-Term Deferred Tax Assets	1.41	1.02	0.98	1.63	4.2	4.88
Long-Term Deferred Charges	15.66	15.66	15.66	15.66	16.26	14.59
Other Long-Term Assets	21	26.73	23.41	19.87	30.92	17.07
Total Assets	1,179	1,182	1,323	862.87	820.06	772.26
Accounts Payable	29.72	20.69	64.53	88.81	55.54	42.53
Accrued Expenses	17.36	26.47	50.18	52.01	36.84	35.41
Short-Term Debt	-	-	44	44	44	-
Current Portion of Long-Term Debt	3.43	3.05	5.19	10.44	9.21	9.6
Current Portion of Leases	3.97	3.72	1.68	2.95	1.84	2.16
Current Income Taxes Payable	3.73	4.03	2.59	2.35	-	3.51
Current Unearned Revenue	2.54	2.84	2.25	2.76	5.12	3.8
Other Current Liabilities	21.47	21.11	27.96	21.54	23.38	19.19
Total Current Liabilities	82.21	81.9	198.38	224.84	175.93	116.21
Long-Term Debt	25.63	28.54	59.69	93.58	104.51	113.89
Long-Term Leases	6.03	8.16	4.81	6.49	1.45	3.29
Long-Term Unearned Revenue	3.23	3.23	3.23	-	18.2	18.2
Pension & Post-Retirement Benefits	-	1.46	1.5	1	1.6	3.29
Long-Term Deferred Tax Liabilities	-	0	-	0.01	-	-
Other Long-Term Liabilities	1.25	-	0.27	0.27	0.16	0.16
Total Liabilities	118.34	123.28	267.88	326.2	301.84	255.02
Common Stock	590.49	590.49	590.49	475.92	475.92	475.92
Additional Paid-In Capital	415.77	415.77	415.77	13.82	13.82	12.09
Retained Earnings	55.8	52.87	48.85	47.04	28.47	42.34
Treasury Stock	-	-	-	-	-	-13.09
Comprehensive Income & Other	-1.28	-0.05	-0.07	-0.11	0.01	-0.02
Shareholders' Equity	1,061	1,059	1,055	536.67	518.22	517.24
Total Liabilities & Equity	1,179	1,182	1,323	862.87	820.06	772.26
Total Debt	39.05	43.46	115.38	157.46	161	128.94
Net Cash (Debt)	477.34	489.52	388.76	-67.52	-102.75	-94.67
Net Cash Growth	-	25.92%	-	-	-	-
Net Cash Per Share	8.08	8.29	7.33	-1.38	-2.11	-1.95
Filing Date Shares Outstanding	59.05	59.05	59.05	49.05	49.05	48.43
Total Common Shares Outstanding	59.05	59.05	59.05	49.05	49.05	48.43
Working Capital	742.52	730.08	782.78	288.9	294.18	312.41
Book Value Per Share	17.96	17.94	17.87	10.94	10.57	10.68
Tangible Book Value	1,058	1,054	1,047	526.43	505.01	502.04
Tangible Book Value Per Share	17.92	17.85	17.73	10.73	10.30	10.37
Land	83.08	83.08	83.08	83.08	83.08	83.08
Buildings	197.04	197.04	196.97	196.6	194.3	192.59
Machinery	112.56	105.32	101.48	93.09	77.69	71.78
Leasehold Improvements	14.39	14.39	10.33	9.76	3.41	2.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.